We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HEMO market cap is 18.74M. The company's latest EPS is GBP -0.0035 and P/E is -4.63.
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.59M | -1.46M | -2.13M | -2.66M | -5.53M |
Net Income | -1.54M | -1.45M | -2.08M | -5.1M | -3.98M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Total Assets | 2.3M | 1.05M | 2.67M | 8.52M | 7.09M |
Total Liabilities | 1.34M | 1.4M | 1.79M | 353k | 3.85M |
Total Equity | 959k | -349k | 876k | 8.17M | 3.24M |
Year End 31 December 2022 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|
GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
Operating | -1.35M | -1.2M | -1.8M | -2.63M | -2.9M |
Investing | -20k | 2k | -170k | -939k | -420k |
Financing | 1.18M | -39k | 3.21M | 8.78M | -110k |
Market Cap | 18.74M |
Price to Earnings Ratio | -4.63 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 7.36 |
Price to Book Ratio | 5.7 |
Dividend Yield | - |
Shares Outstanding | 1.14B |
Average Volume (1 week) | 5.4M |
Average Volume (1 Month) | 10.83M |
52 Week Change | -17.95% |
52 Week High | 6.30 |
52 Week Low | 1.125 |
Spread (Intraday) | 0.04 (2.41%) |
Company Name | Hemogenyx Pharmaceuticals Plc |
Address |
6th floor london EC3V 0HR |
Website | https://hemogenyx.com |
Industry | finance services (6199) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions